Dr. Kathy Rodgers, Associate Director of Translational Neuroscience, and her research team are investigating a drug that may benefit people with Lou Gehrig’s disease.
https://arizonaalumni.com/arizona-magazine/fall-2022/hope-als-patients
For families and patients wanting more information about Allo Phase 2 Clinical Trial: LEARN MORE
For symptomatic peri- and post menopausal women interested in information regarding clinical trial to test the safety and efficacy of PhytoSERM, a potential alternative to hormone therapy. LEARN MORE
Dr. Kathy Rodgers, Associate Director of Translational Neuroscience, and her research team are investigating a drug that may benefit people with Lou Gehrig’s disease.
https://arizonaalumni.com/arizona-magazine/fall-2022/hope-als-patients